Mark has provided business and grant advisory for Australian Biotechnologies and our US business, Origin Biologic since 2015. His deep dive strategies and R&D plans have significantly contributed to our continuous growth.
Simon Berry, CEO, Australian Biotechnologies
Mark has been our advisor, helping us to chart the innovation strategy landscape. With a 100% success rate, he keeps our R&D strategy on track.
Graham Laycock, Managing Director, Qmain
Mark’s strategy services have greatly assisted our business to go from strength to strength over the last five years.
Simon Barbar, CEO, The Jolly Miller & Fig Food Co
For all of our services, we’re not just working for you, but working with you every step of the way.